These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25060891)

  • 1. Metformin pharmacogenomics: biomarkers to mechanisms.
    Wang L; Weinshilboum R
    Diabetes; 2014 Aug; 63(8):2609-10. PubMed ID: 25060891
    [No Abstract]   [Full Text] [Related]  

  • 2. An update on the pharmacogenomics of metformin: progress, problems and potential.
    Todd JN; Florez JC
    Pharmacogenomics; 2014 Mar; 15(4):529-39. PubMed ID: 24624919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the suitability of 19 pharmacogenomics biomarkers for individualized metformin therapy for type 2 diabetes patients.
    Xhakaza L; Abrahams-October Z; Pearce B; Masilela CM; Adeniyi OV; Johnson R; Ongole JJ; Benjeddou M
    Drug Metab Pers Ther; 2020 Jun; 35(2):. PubMed ID: 32681778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin pharmacogenomics: current status and future directions.
    Pawlyk AC; Giacomini KM; McKeon C; Shuldiner AR; Florez JC
    Diabetes; 2014 Aug; 63(8):2590-9. PubMed ID: 25060887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics of oral antidiabetic therapy.
    Ordelheide AM; Hrabě de Angelis M; Häring HU; Staiger H
    Pharmacogenomics; 2018 Apr; 19(6):577-587. PubMed ID: 29580198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current progress in pharmacogenomics of Type 2 diabetes: A systemic overview.
    Guo Z; Priefer R
    Diabetes Metab Syndr; 2021; 15(5):102239. PubMed ID: 34371302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Review of the Impact of Pharmacogenetics and Metabolomics on the Efficacy of Metformin in Type 2 Diabetes.
    Damanhouri ZA; Alkreathy HM; Alharbi FA; Abualhamail H; Ahmad MS
    Int J Med Sci; 2023; 20(1):142-150. PubMed ID: 36619226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WITHDRAWN: Metformin monotherapy for type 2 diabetes mellitus.
    Saenz A; Fernandez-Esteban I; Mataix A; Ausejo Segura M; Roqué i Figuls M; Moher D
    Cochrane Database Syst Rev; 2015 Sep; (9):CD002966. PubMed ID: 26421423
    [No Abstract]   [Full Text] [Related]  

  • 9. Metformin Use and Cognitive Dysfunction Among Patients with Diabetes Mellitus.
    Liccini A; Malmstrom TK; Morley JE
    J Am Med Dir Assoc; 2016 Nov; 17(11):1063-1065. PubMed ID: 27780569
    [No Abstract]   [Full Text] [Related]  

  • 10. Metformin: an alternative treatment for noninsulin-dependent diabetes mellitus.
    Hitt CM
    Conn Med; 1995 Dec; 59(12):727-30. PubMed ID: 8821636
    [No Abstract]   [Full Text] [Related]  

  • 11. Metformin and breast cancer: an opportunity for pharmacogenetics.
    Cuyàs E; Martin-Castillo B; Menendez JA
    Aging (Albany NY); 2022 Jul; 14(14):5612-5613. PubMed ID: 35852878
    [No Abstract]   [Full Text] [Related]  

  • 12. [Metformin and type-2 diabetes mellitus].
    Mata Cases M
    Aten Primaria; 2008 Mar; 40(3):147-53. PubMed ID: 18373928
    [No Abstract]   [Full Text] [Related]  

  • 13. The study to understand the genetics of the acute response to metformin and glipizide in humans (SUGAR-MGH): design of a pharmacogenetic resource for type 2 diabetes.
    Walford GA; Colomo N; Todd JN; Billings LK; Fernandez M; Chamarthi B; Warner AS; Davis J; Littleton KR; Hernandez AM; Fanelli RR; Lanier A; Barbato C; Ackerman RJ; Khan SQ; Bui R; Garber L; Stolerman ES; Moore AF; Huang C; Kaur V; Harden M; Taylor A; Chen L; Manning AK; Huang P; Wexler D; McCarthy RM; Lo J; Thomas MK; Grant RW; Goldfine A; Hudson MS; Florez JC
    PLoS One; 2015; 10(3):e0121553. PubMed ID: 25812009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new perspective on the biguanide, metformin therapy in type 2 diabetes and lactic acidosis.
    Hotta N
    J Diabetes Investig; 2019 Jul; 10(4):906-908. PubMed ID: 31152685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scant evidence on the effectiveness of metformin in type 2 diabetes.
    Perry TL
    BMJ; 2015 May; 350():h2650. PubMed ID: 25990090
    [No Abstract]   [Full Text] [Related]  

  • 16. [Oral hypoglycemic agents and metformin in the treatment of type II non-insulin-dependent diabetes].
    Isnard F
    Sem Hop; 1983 Dec; 59(49):3437-8. PubMed ID: 6320423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin reduces circulating factor VII concentrations in patients with type 2 diabetes mellitus.
    Grant PJ
    Thromb Haemost; 1998 Jul; 80(1):209-10. PubMed ID: 9684819
    [No Abstract]   [Full Text] [Related]  

  • 18. Metformin in 2019.
    Flory J; Lipska K
    JAMA; 2019 May; 321(19):1926-1927. PubMed ID: 31009043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Will delayed release metformin provide better management of diabetes type 2?
    Scheen AJ
    Expert Opin Pharmacother; 2016; 17(5):627-30. PubMed ID: 26830975
    [No Abstract]   [Full Text] [Related]  

  • 20. Comments on "Comparison of repaglinide and metformin versus metformin alone for type 2 diabetes: a meta-analysis of randomized controlled trials".
    Jiang DQ; Li MX; Wang Y
    Diabetes Res Clin Pract; 2015 Apr; 108(1):e1-2. PubMed ID: 25747159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.